Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

The protein C system in placental massive perivillous fibrin deposition.

Svensson AM, Waters BL, Laszik ZG, Simmons-Arnold L, Goodwin A, Beatty BG, Bovill EG.

Blood Coagul Fibrinolysis. 2004 Sep;15(6):491-5.

PMID:
15311158
2.

Significance of perivillous fibrin/oid deposition in uterine evacuation specimens.

Waters BL, Ashikaga T.

Am J Surg Pathol. 2006 Jun;30(6):760-5.

PMID:
16723856
3.

Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence.

Katzman PJ, Genest DR.

Pediatr Dev Pathol. 2002 Mar-Apr;5(2):159-64. Erratum in: Pediatr Dev Pathol. 2003 Jan-Feb;6(1):102..

PMID:
11910510
4.

Genetic polymorphisms in the fibrinolytic system of placentas with massive perivillous fibrin deposition.

Uxa R, Baczyk D, Kingdom JC, Viero S, Casper R, Keating S.

Placenta. 2010 Jun;31(6):499-505. doi: 10.1016/j.placenta.2010.03.013. Epub 2010 May 5.

PMID:
20447686
5.

Coxsackie Virus A16 Infection of Placenta with Massive Perivillous Fibrin Deposition Leading to Intrauterine Fetal Demise at 36 Weeks Gestation.

Yu W, Tellier R, Wright JR Jr.

Pediatr Dev Pathol. 2015 Jul-Aug;18(4):331-4. doi: 10.2350/15-01-1603-CR.1. Epub 2015 Mar 31.

PMID:
25826430
6.

Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report.

Weber MA, Nikkels PG, Hamoen K, Duvekot JJ, de Krijger RR.

Pediatr Dev Pathol. 2006 May-Jun;9(3):234-8.

PMID:
16944973
7.

Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?

Romero R, Whitten A, Korzeniewski SJ, Than NG, Chaemsaithong P, Miranda J, Dong Z, Hassan SS, Chaiworapongsa T.

Am J Reprod Immunol. 2013 Oct;70(4):285-98. doi: 10.1111/aji.12143. Epub 2013 Aug 1.

8.

Ontogenetic and phylogenetic evaluation of the presence of fibrin-type fibrinoid in the villous haemochorial placenta.

Nelson DM, Swanson PE, Davison BB, Baskin GB, Enders AC.

Placenta. 1997 Sep;18(7):605-8.

PMID:
9290158
9.

Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions.

Redline RW, Zaragoza M, Hassold T.

Hum Pathol. 1999 Jan;30(1):93-100.

PMID:
9923934
11.

Massive perivillous fibrinoid causing recurrent placental failure.

Bane AL, Gillan JE.

BJOG. 2003 Mar;110(3):292-5.

12.

Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.

Lambropoulou M, Tamiolakis D, Venizelos J, Liberis V, Galazios G, Tsikouras P, Karamanidis D, Petrakis G, Constantinidis T, Menegaki M, Papadopoulos N.

Clin Exp Med. 2006 Dec;6(4):171-6.

PMID:
17191109
13.

Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Whitten AE, Romero R, Korzeniewski SJ, Tarca AL, Schwartz AG, Yeo L, Dong Z, Hassan SS, Chaiworapongsa T.

Am J Obstet Gynecol. 2013 Apr;208(4):310.e1-310.e11. doi: 10.1016/j.ajog.2013.01.017. Epub 2013 Jan 17.

14.

Recurrent placental massive perivillous fibrin deposition associated with polymyositis: a case report and review of the literature.

Al-Adnani M, Kiho L, Scheimberg I.

Pediatr Dev Pathol. 2008 May-Jun;11(3):226-9. Epub 2007 Aug 28.

PMID:
17990939
16.

Immunohistochemical localization of extracellular matrix in perivillous fibrinoid of normal human term placenta.

Nanaev AK, Milovanov AP, Domogatsky SP.

Histochemistry. 1993 Nov;100(5):341-6.

PMID:
8307776
17.

Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction.

Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD.

BJOG. 2006 May;113(5):580-9. Epub 2006 Mar 27.

18.
19.

Differential lectin binding to the fibrinoid of human full-term placenta: correlation with a fibrin antibody and the PAF-Halmi method.

Lang I, Hartmann M, Blaschitz A, Dohr G, Kaufmann P, Frank HG, Hahn T, Skofitsch G, Desoye G.

Acta Anat (Basel). 1994;150(3):170-7.

PMID:
7817713

Supplemental Content

Support Center